Unidad de Investigación Médica en Enfermedades Nefrológicas, UMAE Hospital de Especialidades, Centro Médico Nacional (CMN) Siglo XXI (SXXI), Instituto Mexicano del Seguro Social (IMSS), Mexico City 06720, Mexico.
Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez-Secretaría de Salud (SS), Mexico City 06720, Mexico.
Int J Mol Sci. 2024 Aug 15;25(16):8895. doi: 10.3390/ijms25168895.
Congenital heart disease (CHD) can be complicated by pulmonary arterial hypertension (PAH). Cardiopulmonary bypass (CPB) for corrective surgery may cause endothelial dysfunction, involving endothelin-1 (ET-1), circulating endothelial cells (CECs), and endothelial progenitor cells (EPCs). These markers can gauge disease severity, but their levels in children's peripheral blood still lack consensus for prognostic value. The aim of our study was to investigate changes in ET-1, cytokines, and the absolute numbers (Ɲ) of CECs and EPCs in children 24 h before and 48 h after CPB surgery to identify high-risk patients of complications. A cohort of 56 children was included: 41 cases with CHD-PAH (22 with high pulmonary flow and 19 with low pulmonary flow) and 15 control cases. We observed that Ɲ-CECs increased in both CHD groups and that Ɲ-EPCs decreased in the immediate post-surgical period, and there was a strong negative correlation between ET-1 and CEC before surgery, along with significant changes in ET-1, IL8, IL6, and CEC levels. Our findings support the understanding of endothelial cell precursors' role in endogenous repair and contribute to knowledge about endothelial dysfunction in CHD.
先天性心脏病(CHD)可并发肺动脉高压(PAH)。用于矫正手术的心肺旁路(CPB)可能导致内皮功能障碍,涉及内皮素-1(ET-1)、循环内皮细胞(CECs)和内皮祖细胞(EPCs)。这些标志物可以评估疾病严重程度,但它们在儿童外周血中的水平对于预后价值仍缺乏共识。我们的研究目的是调查 CPB 手术前 24 小时和后 48 小时 ET-1、细胞因子和 CECs 和 EPCs 的绝对数量(Ɲ)在儿童中的变化,以确定并发症的高危患者。我们纳入了 56 名儿童的队列:41 例 CHD-PAH(22 例高肺血流和 19 例低肺血流)和 15 例对照组。我们观察到 CHD 两组中的 Ɲ-CECs 增加,而在手术后即刻期 Ɲ-EPCs 减少,手术前 ET-1 和 CEC 之间存在强烈的负相关,以及 ET-1、IL8、IL6 和 CEC 水平的显著变化。我们的发现支持了对内皮细胞前体细胞在体内修复中作用的理解,并有助于了解 CHD 中的内皮功能障碍。